関連する実験動画
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
ホールドーピングマンガニートの混合相状態における磁化分布
Y Murakami1, J H Yoo, D Shindo
1Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980-8577, Japan. murakami@tagen.tohoku.ac.jp
Nature
|June 27, 2003
まとめ
マンガナイトの巨大磁気抵抗 (CMR) は,その複雑な磁気微細構造と関連しています. 磁場を適用すると,この繊細な構造が変化し,伝導経路が可能になり,CMR材料で観察される異常な抵抗性低下を引き起こします.
科学分野:
- 凝縮物質物理学 凝縮物質物理学
- マテリアルサイエンス 材料科学
- マグネチズム (磁気) とは
背景:
- ホールドーピングされたマンガナイトの巨大磁気抵抗 (CMR) は,磁場を適用した下での抵抗力の大きな減少によって特徴づけられる重要な現象です.
- CMRを駆動する正確なメカニズムは,まだ完全に理解されていませんが,磁気と非磁気相の共存を含む相分離状態は,決定的に重要と考えられています.
- この混合相状態内の詳細な磁気マイクロ構造は,CMRに影響を与える重要な未知の要因です.
研究 の 目的:
- La(1-x) Sr(x) MnO3 (x = 0.54, 0.56) の混合相状態における磁性マイクロ構造とフェロ磁性領域の進化を調査する.
- 磁気微細構造と洞穴ドーピングされたマンガナイトにおける巨大な磁気抵抗効果の関係を解明する.
主な方法:
- 電子顕微鏡を用いて磁石の微細構造を調べました.
- La(1-x) Sr(x) MnO3サンプルの混合相状態におけるフェロ磁気ドメインの発展を研究した.
主要な成果:
- 磁場がない場合,磁気流はフェロ磁気領域に閉じ込められ,分離したフェロ磁気領域間の相互作用が最小限であることを観察した.
- フェロ磁気領域がわずかな気温変動でだけ融合し始めることを実証した.
- これらの材料の混合相状態における微妙な磁気微細構造を特定した.
結論:
- 穴ドーピングされたマンガナイトの混合相状態の微妙な磁気微細構造は,巨大な磁気抵抗効果の主要な要因として提案されています.
- 磁場の適用は,磁気領域間の重要な伝導経路の形成を促進し,CMRにつながることが示されています.
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K